arrow
S

Silvestre Vicent

Navarrabiomed
H指数:34
被引数:3,581

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Trametinib sensitizes KRAS-mutant lung adenocarcinoma tumors to PD-1/PD-L1 axis blockade via Id1 downregulation

曲美替尼通过Id1下调使KRAS突变型肺腺癌肿瘤对PD-1/PD-L1轴阻滞敏感

2024-04-201
OAAI
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma

用于预测遗传异质性多发性骨髓瘤的免疫治疗结果和免疫逃避机制的临床前模型

2023-03-1628
OAAI
Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis
2022-03-0161
PRE
Tumor ENPP1 (CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast Cancer
2022-02-2131
OAAI
The Mir181ab1 cluster promotes KRAS-driven oncogenesis and progression in lung and pancreas
2020-03-0928
OAAI
Short-term starvation reduces IGF-1 levels to sensitize lung tumors to PD-1 immune checkpoint blockade

短期饥饿降低IGF-1水平,使肺肿瘤对PD-1免疫检查点阻滞敏感

2020-01-1393
PREAI
Inhibitor of Differentiation-1 Sustains Mutant KRAS-Driven Progression, Maintenance, and Metastasis of Lung Adenocarcinoma via Regulation of a FOSL1 Network
2019-02-0124
OAAI
Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis by CXCL16-mediated Effects
2018-05-0159
OAAI